The Leukaemias - FAR TOO MANY CELLS; FAR TOO MANY VOWELS - toby m robins.

Slides:



Advertisements
Similar presentations
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Advertisements

HAEMATOLOGY MODULE: LYMPHOMA Adult Medical-Surgical Nursing.
A Hematology Case Study about Leukemia by Sarah Wycoff
Acute leukemia Mohammed Al-matrafi.
HAEMATOLOGY MODULE: LEUKAEMIA (LECTURE 1) CHEMOTHERAPY Adult Medical-Surgical Nursing.
Introduction To Haematological Malignancies
LEUKEMIA.
Chronic leukaemias Chronic myelogenous leukaemia Chronic myelogenous leukaemia Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia.
Common Haematological Malignancies
Acute Lymphoblastic Leukemia Maggie Davis Hovda 5/26/2009.
Leukemia and Lymphoma Dental Views By Fatin Al – Sayes MD, Msc,FRcpath Associate Professor Consultant Hematology Leukemia and Lymphoma Dental Views By.
Acute Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH.
Acute lymphoblastic leukemia (ALL)
ACUTE MYELOID LEUKEMIA Irit Avivi
LEUKEMIAS Dr Mehboob Khan Pathologist
Acute leukemia Aggressive malignant hematopoietic disorders
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
CHRONIC MYELOID LEUKAEMIA Dr Rosline Hassan Department of Haematology School of Medical Sciences Universiti Sains Malaysia.
Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.
Acute Myeloid Leukemias (AML)
Myelodysplastic syndrome overview Razelle Kurzrock Seminars in Haematology, Vol 39, No 3, Suppl 2 (July) 2002, pp
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
Acute Leukemia: Clinical Cases and Correlates Daniel A. Nikcevich, MD, PhD Duluth Clinic Cancer Center May 13, 2008.
Leukemia & Lymphoma Keith Rischer, RN, MA, CEN. Leukemia Patho Loss of regulation in cell division, causes proliferation of malignant leukocytes Classification.
Acute Myeloid Leukemia. Case Presentation 33 yo Filipino male presents with back pain, fevers, weight loss, and general malaise 33 yo Filipino male presents.
LIBYAN EXPERIENCE IN PEDIATRIC ACUTE MYELOID LEUKEMIA Fathia El Riani, Rasem Al Ajnef, Elham Sbita, Salem Zarroug Departement of pediatric hematology-oncology.
Cancer of the blood: Leukemia
Myelodysplastic Syndrome (MDS)
The myelodysplastic syndromes (MDS) Aquired Clonal disease of BM. comprise a heterogeneous group of malignant stem cell disorders characterized by : 1.
Leukemia.
Leukemia By: Gabie Gomez. What is Leukemia? Blood consists of plasma and three types of cells, each type has a special function. RBC, WBC and Platelets.
4th Year Medical Student KAU
Chronic myeloid leukaemia Cancer of granulocyte production Too many (non functioning) granulocytes are produced Bone marrow is overcrowded with ineffective.
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Chronic myeloid leukaemia (CML)
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
Associate professor of Internal Medicine
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
Acute myeloid leukemia
MLAB 1415: Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Acute Leukemia Kristine Krafts, M.D..
Treatment. Phases of treatment Induction chemotherapy Postremission therapy *Initial goal: quickly induce CR *Therapy depends on patient age.
Leukemia. What is Leukemia?  Leukemia is a cancer of the blood  It is the most common type of blood cancer beginning in the bone marrow where abnormal.
Case 251: Clinical Information Raymond E Felgar, MD, PhD University of Pittsburgh, Pittsburgh, PA 45-year-old man with recent history of shingles, night.
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Acute lymphoblastic leukemia in children
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
Hematology There are four lectures: 1.Acute leukemias (2 hours). 2.Chronic leukemias (2 hours).
Acute leukemias.
Acute Leukemia Kristine Krafts, M.D..
Haematological Malignancies
Childhood leukemias Prof. Dr. P. Kajtár.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
11 th lecture Chronic myeloid leukaemia By DR Fatehia Awny Faculty of Health Science Beirut Arab University
Asuhan Keperawatan Pasien Anak dengan Acut Lymphoblastic Leukemia
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Hematology Journal Club
Case:2 leukemia دينا نعمان جرادة جيهان ايمن مقاط.
Acute leukemia.
Leukemia.
Acute Leukemia Dr. Noha Noufal.
Neoplastic disorder.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Presentation transcript:

The Leukaemias - FAR TOO MANY CELLS; FAR TOO MANY VOWELS - toby m robins

Leukaemia may be Acute or Chronic

and it may be Lymphoblastic or Myeloid

Put that all together and you get Acute lymphoblastic leukaemia Acute myeloid leukaemia Chronic lymphoblastic leukaemia Chronic myeloid leukaemia

For each, we will briefly cover Definition Epidemiology Aetiology Pathogenesis Clinical features Investigations Management Prognosis

but first What exactly IS leukaemia?

Leukaemia is Production

of abnormal WBCs

at an excessive rate

+/- reduced destruction

i.e. it is malignancy of the leukocytes

and it is clonal - ie all the malignant cells have a recent common ancestor

it is classified according to 1. the dominant cell type and 2. the duration from onset to death

Chronic leukaemia Untreated, exceeds one year (with gradual onset of symptoms)

Acute leukaemia Untreated, death ensues within a few months

The acute ones ALL (acute lymphoblastic leukaemia) AML (acute myeloid leukaemia)

firstly Acute Myeloid Leukaemia

Definition of AML Neoplastic proliferation of myeloid blast cells

Myeloid blast cells explained Mature blood cells are derived originally from pluripotent stem cells

Meyloid blast cells explained Pluripotent stem cells then divide and differentiate either into myeloid stem cells or lymphoid stem cells M L

Myeloid blast cells explained Lymphoid stem cells make lymphocytes Myeloid stem cells make all the other blood cells

SEW

There’s more than ONE kind of AML Morphologically, there are seven and a half: – M1 = undifferentiated blast cells – M2 = myeloblastic – M3 = promyelocytic – M4 = myelomonocytic – M4 eo = myelomonocytic with dysplastic eosinophils – M5 = monocytic – M6 = erythroleukaemia – M7 = megakaryoblastic leukaemia

Epidemiology 70-year-old, male, Eastern European Jews

Aetiology ?

All implicated have been – Heredity – Radiation – Mutagenic drugs – Chemical & other occupational exposures – secondary to previous chronic leukaemia or myelodysplasia

Clinical features Symptoms and signs are a result of 3 things: – 1. Marrow failure – 2. Leukaemic infiltration of tissues – 3. Consitutional upset

Symptoms relating to marrow failure Infection Bleeding or easy bruising symptoms of anaemia - shortness of breath, etc

Symptoms relating to leukaemic infiltration Symptoms of a mass lesion (rarer, since leukaemias by definition tend not to form masses) – bone – breast, uterus, ovary – cranial or spinal dura – GI tract – lung or mediastinum – prostate

Symptoms relating to constitutional upset Malaise Fatigue Weakness Fever or sweats Anorexia or weight loss Non-specific cough

Signs relating to marrow failure Evidence of infection Signs of anaemia Purpura or signs of bruising/bleeding – including retinal haemorrhages

Signs relating to leukaemic infiltration Hepatosplenomegaly Lymphadenopathy Sternal tenderness Thymic mass Gingival hypertrophy

Signs relating to constitutional upset Fever

Investigations FBC Blood film U&Es LFTs coagulation (especially for the DIC of M3) Bone marrow examination cell markers and molecular studies (eg of marrow cells)

FBC Anaemia Neutropenia Thrombocytopenia

Blood film Blast cells that contain – granules – Auer rods

U&Es, LFTs The following are occasionally increased – calcium – urea – LFTs

Bone marrow examination Blast cells constituting > 20% of the bone marrow cells is diagnostic

Cell markers, molecular studies Flow cytometry (immunophenotyping) may aid in morphological (ie appearance-based) diagnosis and may add further prognostic information Karyotyping, FISH, and PCR may confirm diagnosis (eg acute promyelocytic leukamia; =M3), + may add information not otherwise obtainable

Management includes Intensive chemotherapy Bone marrow transplant Supportive care

Chemotherapy Divided into 3 phases – 1. Remission induction – 2. Remission consolidation – 3. Remission maintenance

1. Chemotherapy for remission induction Complete remission (CR) – full recovery of haematopoiesis, with – blasts accounting for < 5% of bone marrow cells Involves mainly – anthracyclines – cytosine arabinoside

Why have they chosen these drugs? Anthracyclines – because AML is like cycling a “myel” and a half with anthrax Cytosine arabinoside – think “sight-o-seen arabocide” – because some (ignorant,misinformed,prejudiced) people because think an Arab that comes within a “myel” radius should be shot on sight – sorry, Tarik, no offence :)

2. Chemotherapy for remission consolidation Involves similar chemotherapy to that of remission induction

3. Chemotherapy for remission maintenance Treatment is continued for 2 years in ALL, but for a much shorter time in AML

Bone marrow transplant (BMT) Suitable marrow may be – allogeneic (from histocompatible siblings or unrelated donors) – syngeneic (from an identical twin) – autologous

BMT continued Used increasingly as a form of consolidation Use depends on the pt’s age – the elderly develop more complications

BMT continued Marrow is infused intravenously to “rescue” the pt from otherwise supralethal chemoradiotherapy Enables destruction of (almost) all leukaemic cells and the entire immune system with eg cyclophosphamide plus total body irradiation

Why use cyclophosphamide? ‘cause you midas well make phossels out of all those nasty leukaemia cells in one foul swoop (cycle) A FOUL SWOOP

BMT continued To reduce graft vs host effect – cyclosporin +/- – methotrexate Complications – graft vs host disease – infections (commonly CMV) – veno-occlusive disease – relapse of leukaemia

Supportive treatment Blood transfusion for anaemia Platelet transfusion for thrombocytopenic bleeding Prompt antibiotic treatment, and prevention, of infections Hygeine

Prognosis 70% achieve complete remission lasting (on average) 12 months Long-term survival (~ 50%)

Secondly Acute Lymphoblastic Leukaemia

Definition Neoplastic proliferation of lymphoblasts

Types of ALL Common – phenotypically pre-B lymphocytes – 75% of cases T-cell B-cell Null-cell

Aetiology as for AML

Epidemiology (Common ALL) 4-year-olds

Epidemiology (T-cell ALL) Adolescent males

Clinical features as for AML

Investigations As for AML Blood film shows –small blasts with –a high nuclear-cytoplasmic ratio